Orly Weinreb

род занятий: исследователь

Серия

There is nothing here

Создать новую серию

Произведения

There is nothing here

Создать новое произведение

Статьи 79

Дата

Заголовок

Авторы

2018-07-17

A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist

Bilha Fischer, Moussa B. H. Youdim, Orly Weinreb
2017-05-29

The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models

Orly Weinreb, Moussa B. H. Youdim, Danit Mechlovich, Lana Kupershmidt
2017-04-11

The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia

Moussa B. H. Youdim, Nina Mandiuk, Orly Weinreb
2017-10-01

Iron-Chelating Drugs Enhance Cone Photoreceptor Survival in a Mouse Model of Retinitis Pigmentosa

Bo Peng, Bin Lin, Moussa B. H. Youdim, Orly Weinreb
2016-05-13

Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1(G93A) Transgenic ALS Mice.

Moussa B. H. Youdim, Sagit Golko-Perez, Orly Weinreb
2016-10-28

Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells

Orly Weinreb, Moussa B. H. Youdim
2016-06-15

Design, synthesis and evaluation of novel dual monoamine-cholinesterase inhibitors as potential treatment for Alzheimer's disease

Orly Weinreb, Moussa B. H. Youdim
2016-11-08

A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice.

Moussa B. H. Youdim, Sagit Golko-Perez, Orly Weinreb
2015-08-29

Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease

Orly Weinreb, Moussa B. H. Youdim
2015-04-10

Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets

Orly Weinreb
2015-11-18

Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis

Orly Weinreb, Moussa B. H. Youdim, S Mandel, Lana Kupershmidt, Sagit Golko-Perez
2015-07-01

The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease

Orly Weinreb
2015-05-21

Effect of long-term treatment with rasagiline on cognitive deficits and related molecular cascades in aged mice

Moussa B. H. Youdim, Felix Badinter, Orly Weinreb
2015-06-15

Beneficial behavioral, neurochemical and molecular effects of 1-(R)-aminoindan in aged mice.

Moussa B. H. Youdim, Felix Badinter, Orly Weinreb
2015-05-01

Improvement in verbal memory following SSRI augmentation of antipsychotic treatment is associated with changes in the expression of mRNA encoding for the GABA-A receptor and BDNF in PMC of schizophrenic patients.

Moussa B. H. Youdim, Nina Mandiuk, Ehud Susser, Lena Danovich, Orly Weinreb
2014-02-01

The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.

Moussa B. H. Youdim, S Mandel, Danit Mechlovich, Orly Weinreb
2014-12-01

Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus

Orly Weinreb, Moussa B. H. Youdim, Danit Mechlovich
2014-01-01

Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease

Orly Weinreb, Moussa B. H. Youdim, Lana Kupershmidt
2014-01-06

DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline

Orly Weinreb, Moussa B. H. Youdim, S Mandel
2014-10-22

Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.

Moussa B. H. Youdim, Danit Mechlovich, Lana Kupershmidt, Orly Weinreb
2013-01-01

The role of GABA-A receptor in the synergism between SSRI and antipsychotic in schizophrenia; implications for antipsychotic modes of actions

Orly Weinreb, Moussa B. H. Youdim
2013-01-30

Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators

Orly Weinreb, Moussa B. H. Youdim, S Mandel
2012-01-01

Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols

Orly Weinreb, Moussa B. H. Youdim, S Mandel
2012-04-01

Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment

Orly Weinreb, Moussa B. H. Youdim
2012-03-25

Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism

Orly Weinreb, Moussa B. H. Youdim, S Mandel, Danit Mechlovich
2012-07-31

Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.

Moussa B. H. Youdim, Lana Kupershmidt, Orly Weinreb
2012-03-10

Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.

Moussa B. H. Youdim, Lana Kupershmidt, Orly Weinreb
2012-04-17

The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.

Moussa B. H. Youdim, Lana Kupershmidt, Orly Weinreb
2011-10-12

Chronic treatment with serotonin reuptake inhibitor antidepressant (SSRI) combined with an antipsychotic regulates GABA-A receptor in rat prefrontal cortex.

Moussa B. H. Youdim, Lena Danovich, Orly Weinreb
2011-03-01

Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim

Orly Weinreb, S Mandel
2011-01-01

Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases

Orly Weinreb, Moussa B. H. Youdim, S Mandel
2011-01-01

Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease

Orly Weinreb, Moussa B. H. Youdim, S Mandel, Peter Riederer

Human - wd:Q67224441

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше